This chapter provides an overview of the hematological cancers, that is, the leukemias and myelodysplastic syndromes, and focuses in depth on cytogenetics and biomarkers used to diagnose these cancers, and to distinguish these cancers from each other. Use of gene arrays is shown by data from a clinical trial.